SSC: On Land, In Space

WASHINGTON—This month’s deadline for submitting proposals for the $44 billion Superconducting Supercoilider has left the Department of Energy with 43 places to put the world’s biggest scientific construction project. All of the states expected to be in the running (see THE SCIENTIST, March 9, p. 1) submitted their bids on time, although California’s arrived with only eight minutes to spare after a legislative fight on affirmative action hiring goals. Some states couldn

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—This month’s deadline for submitting proposals for the $44 billion Superconducting Supercoilider has left the Department of Energy with 43 places to put the world’s biggest scientific construction project.

All of the states expected to be in the running (see THE SCIENTIST, March 9, p. 1) submitted their bids on time, although California’s arrived with only eight minutes to spare after a legislative fight on affirmative action hiring goals. Some states couldn’t decide on a preferred site, so they submitted multiple proposals. A handful of contenders who had been snubbed by their states managed to put together their own packages. And there’s even one bid that’s out of this world.

“It doesn’t need to be a hole in the ground,” declared Paul Jablonka, a part-time graduate student in computer sciences at the University of Arizona whose proposal calls for the SSC to be located in orbit. Jablonka believes that putting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies